Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,747,897
+$14,490 QoQ
Shares Held
11,153
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#465
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTRUST BANK NA holds $44,865,794 across 13 Drug Manufacturers - General names. NVS ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,489 | $13,780,251 | |
| 2 | ABBV |
AbbVie Inc.
|
26,654 | $6,707,212 | |
| 3 | JNJ |
Johnson & Johnson
|
24,382 | $6,192,296 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,996 | $3,725,986 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
24,402 | $3,082,948 | |
| 6 | AMGN |
Amgen Inc
|
7,840 | $2,839,020 | |
| 7 | AZN |
Astrazeneca PLC
|
10,427 | $1,977,167 | |
| 8 | NVS |
Novartis AG
This page
|
11,153 | $1,747,897 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,747,897 | 11,153 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,733,407 | 11,348 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,504,160 | 10,910 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,354,085 | 10,559 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,278,711 | 10,567 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,185,812 | 10,637 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,061,943 | 10,913 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,224,732 | 10,648 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,116,445 | 10,487 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,128,258 | 11,664 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,250,310 | 12,383 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,138,895 | 11,181 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,093,863 | 10,840 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $967,748 | 10,519 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $848,141 | 9,349 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $583,148 | 7,672 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $672,266 | 7,953 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $583,537 | 6,650 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $426,591 | 4,877 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $437,604 | 5,351 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $564,045 | 6,182 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $441,504 | 5,165 | Shares | Sole | 2021-06-02 | |
| 2020-12-31 | $451,185 | 4,778 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||